Welcome to Arctom, sign up to enjoy up to
20% OFF
+1 800-931-7508
[email protected]
Search in Small Molecules
Search in Biologics
Structure Search
Sign in
Register
Cart - 0 item(s)
$0.00
Your shopping cart is empty!
Building Blocks
Alcohols and Derivatives
Amines and Anilines
Amino Acids and Derivatives
Boronic Acids and Esters
Carbonyl Compounds
Halides
Heterocycles
Nitrogen Compounds
Phosphorus Compounds
Sulfur Compounds
Functional Material
Oxygen Compounds
Chemistry
Inhibitors
Natural Products
Antibodies
ADCs
Toxins
Linkers
Payloads with linkers
Miscellaneous
Material Science
Others
Catalysts
Rare Earth Metal Compounds
Transition Metal Compounds
Other
Chiral Compound
Chiral Reagents/Auxiliary
Lithium Reagent
Grignard Reagents
Silylating Reagents
Organosilicon Compounds
Inorganic Salts
Inorganic Compounds
Coupling Reagent
Oxidant
Reductant
Sugars
Rock
Tin Compounds
Our clients include world's top universities and pharmaceutical organizations
Astellas Pharma
Thursday, March 28, 2024
China’s National Medical Products Administration Accepts Astellas and Pfizer’s Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Chugai Pharmaceutical
Wednesday, March 27, 2024
Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Viatris
Wednesday, March 27, 2024
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
Merck
Tuesday, March 26, 2024
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
AACR Annual Meeting 2024
Friday, April 5, 2024
San Diego, California
2024 AAN Annual Meeting
Saturday, April 13, 2024
Denver, CO
2024 USASP Annual Scientific Meeting
Sunday, April 14, 2024
Seattle, Washington
New England Journal of Medicine
Wednesday, March 20, 2024
Intrathecal Gene Therapy for Giant Axonal Neuropathy
New England Journal of Medicine
Wednesday, March 20, 2024
Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency
New England Journal of Medicine
Wednesday, March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast Cancer
New England Journal of Medicine
Wednesday, March 20, 2024
Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure
52
52
BSGCT Public and Patient Engagement Series: "mRNA therapy in inherited metabolic diseases"
37
37
Updates on CAR-T and BCMA Antibodies in Multiple Myeloma
211
211
CRISPR CAS9 Step by step explanation.
426
426
Young breast cancer survivor spreads awareness
Chugai Pharmaceutical
Tuesday, March 26, 2024
Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA, AKT1 or PTEN Alterations
Bristol-Myers Squibb
Tuesday, March 26, 2024
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
Astellas Pharma
Tuesday, March 26, 2024
Astellas’ VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Chugai Pharmaceutical
Monday, March 25, 2024
Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials
45th SIMD Annual Meeting
Sunday, April 14, 2024
Charlotte, NC
22nd BTOG Annual Conference 2024
Wednesday, April 17, 2024
Belfast, UK
2024 PENS National Conference
Wednesday, April 17, 2024
St. Louis, MO
Lancet
Tuesday, March 19, 2024
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Lancet
Tuesday, March 19, 2024
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Nature Medicine
Monday, March 18, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Nature Medicine
Monday, March 18, 2024
Heterogeneity and predictors of the effects of AI assistance on radiologists
105
105
CRISPR Technology: Role of CRISPR gene editing in Cancer Research Landscape #crispr #biotech
20
20
TNM 9th edition of lung cancer.
28
28
Immune-related adverse events in breast cancer patients taking ICIs
73
73
Use of checkpoint inhibitors in breast cancer treatment
Chugai Pharmaceutical
Monday, March 25, 2024
Chugai Obtains Regulatory Approval for “Piasky 340mg” for Paroxysmal Nocturnal Hemoglobinuria in Japan
Chugai Pharmaceutical
Monday, March 25, 2024
Chugai Obtains Regulatory Approval for Vabysmo, the Only Bispecific Antibody in the Ophthalmology Field, for Additional Indication of Macular Edema Associated with Retinal Vein Occlusion
Regeneron Pharmaceuticals
Monday, March 25, 2024
Regeneron Provides Update on Biologics License Application for Odronextamab
AbbVie
Monday, March 25, 2024
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
ECCMID 2024
Saturday, April 27, 2024
Barcelona, Spain
10th Annual ELITE PED-GI Congress 2024
Thursday, May 2, 2024
Abu Dhabi, United Arab Emirates
2024 PES Annual Meeting
Thursday, May 2, 2024
Chicago, IL
Nature
Monday, March 18, 2024
Long-term continuous ammonia electrosynthesis
Nature Medicine
Monday, March 18, 2024
A visual-language foundation model for computational pathology
Nature Medicine
Monday, March 18, 2024
Towards a general-purpose foundation model for computational pathology
Nature
Sunday, March 17, 2024
Structural insights into vesicular monoamine storage and drug interactions
24
24
CRISPR-Cas9: The Future of Genetic Engineering
274
274
Real-World CAR-T Data Update
125
125
CRISPR & HIV
191
191
Allergen immunotherapy Vaccine dose कितना दिन तक लेना चाहिए? Immunotherapy for Allergy free Life
AbbVie
Monday, March 25, 2024
Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics
Bristol-Myers Squibb
Monday, March 25, 2024
Bristol Myers Squibb to Present Data at the American College of Cardiology Annual Scientific Session 2024 Reinforcing Extensive Body of Evidence in Clinical and Real-World Settings Across Cardiovascular Portfolio
Astellas Pharma
Monday, March 25, 2024
Astellas Receives Positive CHMP Opinion for XTANDITM in Additional Recurrent Early Prostate Cancer Treatment Setting
Novartis
Friday, March 22, 2024
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
2024 AANS Annual Scientific Meeting
Friday, May 3, 2024
Chicago, IL
ATA Nexus 2024
Sunday, May 5, 2024
Phoenix, AZ
ACOOG 91st Annual Conference
Sunday, May 5, 2024
Bonita Springs, Florida
Science
Thursday, March 14, 2024
Diversity begets stability: Sublinear growth and competitive coexistence across ecosystems
Science
Thursday, March 14, 2024
Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans
Science
Thursday, March 14, 2024
Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Science
Thursday, March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against
131
131
The world’s first vaccine to prevent lung cancer | Tech & Science Daily podcast
118
118
US gov. sues Apple, lung cancer vaccine, microplastics at Roman dig | Tech & Science Daily podcast
275
275
CRISPR could disable and cure HIV, suggests promising lab experiment
214
214
Why breast cancer is on the rise
Not More
Show More
loading...